ALK-positive large B-cell lymphoma with strong CD30 expression; a diagnostic pitfall and resistance to brentuximab and crizotinib

We report a case of ALK positive large B-cell lymphoma (ALK-LBCL) with strong CD30 expression, initially misdiagnosed as anaplastic large cell lymphoma (ALCL), ALK positive. These two lymphomas differ in response to chemotherapy and prognosis making accurate diagnosis essential.

This article is protected by copyright. All rights reserved.

from #ORL-Sfakianakis via xlomafota13 on Inoreader http://ift.tt/1X7usI8
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1NYbfW2
via IFTTT